.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
US Army
Citi
Novartis
Daiichi Sankyo
Harvard Business School
Colorcon
US Department of Justice
Fish and Richardson
Merck

Generated: September 26, 2017

DrugPatentWatch Database Preview

Testosterone undecanoate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for testosterone undecanoate and what is the scope of testosterone undecanoate patent protection?

Testosterone undecanoate
is the generic ingredient in one branded drug marketed by Endo Pharms Inc and is included in one NDA. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Testosterone undecanoate has forty-eight patent family members in thirty-seven countries.

There are sixty-one drug master file entries for testosterone undecanoate. One supplier is listed for this compound.

Summary for Generic Name: testosterone undecanoate

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list61
Suppliers / Packagers: see list1
Bulk Api Vendors: see list35
Clinical Trials: see list742
Patent Applications: see list1,012
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:testosterone undecanoate at DailyMed

Pharmacology for Ingredient: testosterone undecanoate

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms Inc
AVEED
testosterone undecanoate
INJECTABLE;INTRAMUSCULAR022219-001Mar 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Endo Pharms Inc
AVEED
testosterone undecanoate
INJECTABLE;INTRAMUSCULAR022219-001Mar 5, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Endo Pharms Inc
AVEED
testosterone undecanoate
INJECTABLE;INTRAMUSCULAR022219-001Mar 5, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: testosterone undecanoate

Country Document Number Estimated Expiration
Canada2518910► Subscribe
Norway335179► Subscribe
Serbia20050702► Subscribe
Taiwan200511997► Subscribe
Russian Federation2007118196► Subscribe
Eurasian Patent Organization200501819► Subscribe
New Zealand542321► Subscribe
Costa Rica7999► Subscribe
Iceland2565► Subscribe
MexicoPA04002395► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Moodys
Colorcon
Novartis
Argus Health
Healthtrust
US Department of Justice
Daiichi Sankyo
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot